\
&
Contact us
Published on | 1 year ago
ProgrammesThe European Partnership for Personalised Medicine (EP PerMed) has launched its second joint transnational call (JTC2025) for proposals on “Pharmacogenomic strategies for personalised medicine approaches (PGxPM2025)”. In total, 35 funding organisations participate in this call with an available budget of over € 36.5 Mio.
The topics of this call are the following:
Pay attention: projects focussing only on drug-drug-interaction and projects focusing on the clinical development of new drugs are not eligible.
Research Foundation Flanders (FWO) participates in this call. More information on available funding for researchers based in Flanders and on how to apply can be found on the dedicated FWO webpage. Interested to apply? Contact the FWO advisors at europe@fwo.be. Deadline for pre-proposal submission AND national pre-application via the FWO e-loket is 18 February 2025, 14:00 CET.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space EIT Deployment: Best use of technologies
The Co-Creation Accelerator is a programme run by 28DIGITAL (formerly EIT Digital). It brings together start-ups and industry partners to co-develop solutions to real-world challenges, with a focus on: Validating core technology (TRL 4-5 and above) Strengthening problem-solution fit Reducing technical and market uncertainty Building a cle... read more
ENGIE Laborelec contributed to the Cluster 3 project DYNAMO by leveraging its Digital Twin to simulate and test solutions aimed at strengthening the cybersecurity of critical infrastructures, while also providing valuable end-user insights to support the project's objectives.